Furthermore, GLP-1 RAs have only been shown in several small studies and subset analysis of clinical trials in both diabetic and nondiabetic population to contribute to the management of blood pressure lowering, lipid reduction, prevention of PCOS complications, and contribution of assisting weight management in bariatric surgical patients. Here, GLP1R is linked to polycystic ovary syndrome.